A 760-yuan pill, a 220-yuan cut: insurance loophole goes viral
A prized Chinese remedy is being run through insurance swipes — and a broker walks away with the change.
Swipe medical insurance for 760 yuan, hand it over for a single capsule of Pianzaihuang, and a broker cheerfully pockets 220 of that — that little script just climbed the trending charts. The storied remedy, usually parked at center stage of the family medicine cabinet, has been propped up on a card reader and handed an unexpected cameo as someone's personal ATM.
The cut looks small; the playbook isn't. Pianzaihuang already commands a steep price thanks to musk and bezoar in its formula, so it's supposed to be a precious healer, not a cash-out channel. Yet insurance money keeps sliding quietly into a middleman's hands, one pill at a time.
Patients are still lining up for care they can barely afford, while a scarce old remedy is being put to a use its label never advertised. The show isn't over, but Pianzaihuang's star polish is starting to fade.